BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT07780266 updates: 1. enrollment: 20 → 36 participants 2. intervention model: PARALLEL → CROSSOVER 3. masking: NONE → SINGLE
Clinical trial NCT07780266 updates: 1. enrollment: 20 → 36 participants 2. intervention model: PARALLEL → CROSSOVER 3. masking: NONE → SINGLE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical